CVS Caremark stopped covering a GLP-1 for obesity. Now there's a lawsuit | CNN

Prescription drugs Food & health See all topics Facebook Tweet Email Link Link Copied! Follow A class-action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly’s blockbuster GLP-1 drug to trea
Read more...